2007 Press Releases

• Tranzyme Pharma to Present at the 26th Annual JPMorgan Healthcare Conference

  December 19, 2007

• Tranzyme Pharma Closes New $20 Million Financing

  November 1, 2007

• Tranzyme Pharma Initiates Dosing of Patients in a Multi-National Phase IIb Clinical Trial for the Treatment of Severe Gastroparesis

  October 30, 2007

• Tranzyme Pharma's Motilin Antagonist TZP-201 Shows Potential for Preventing and Treating Chemotherapy-Induced Diarrhea (CID)

  October 24, 2007

• Tranzyme Pharma Initiates Dosing of Patients in a Multi-National Phase IIb Clinical Trial with its Novel Ghrelin Agonist, TZP-101, for Post-Operative Ileus

  July 26, 2007

• Tranzyme Pharma Receives FDA Fast Track Designation for its Novel Ghrelin Agonist, TZP-101, for the Treatment of Severe Gastroparesis

  July 12, 2007

• Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis

  June 26, 2007

Archives

• 2009 Press Releases
• 2008 Press Releases
• 2007 Press Releases
• 2006 Press Releases
• 2005 Press Releases
• 2004 Press Releases
• 2003 Press Releases